α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors
US7495022B2 · kind B2 · utility
9Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 2003 |
| Grant date | Feb 24, 2009 |
| Priority date | — |
| Expiry date | Nov 24, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/155
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are agents that inhibit histone deacetylase. More specifically, the present invention relates to novel hydroxamic acid derivatives or pharmaceutically acceptable salts thereof for anticancer agents or other therapeutic agents based on their histone deacetylase inhibitory activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.